Analysis of 47 Patients with Triple Negative (ER, PGR, HER2) Breast Cancer

Gunes M. E., Celik G., Trabulus F. D., Aksoy S., Ozoran E., Aren A., ...Daha Fazla

ISTANBUL MEDICAL JOURNAL, cilt.13, sa.4, ss.166-168, 2012 (ESCI, TRDizin) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 4
  • Basım Tarihi: 2012
  • Doi Numarası: 10.5505/1304.8503.2012.96158
  • Dergi Adı: ISTANBUL MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.166-168
  • Anahtar Kelimeler: HER2, breast cancer, estrogene receptor, progesterone receptor
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Objectives: Breast cancer is the most common cancer in women. Breast cancer responds variable depending on morphological, clinical, hormonal receptor level differences. In current medical practice ER, PGR, HER2 levels have been important prognostic factors changing the outcome and the treatment modalities.